Rules on prevention of falsified medicines - safety features

The EU has issued rules on prevention of falsified medicines that are to apply from 9 February 2019 (see namely Commission Delegated Regulation 2016/161).

Denmark has revised its Executive Order on Labelling etc. of Medicines (Danish language) to reflect the change in rules concerning safety features.

Some of the rules are a reiteration of the EU rules that already directly apply - however, they are included for practical purposes. It should be noted that Denmark has used its discretionary powers to allow for all types of medicinal products to have an anti-tampering device.

Latest news on Life Science

Life Science